A second hypothesis that has gained traction is that KOR antagonists may reduce depressive-like symptoms that characterize numerous psychiatric disorders including major depressive disorder (MDD), post-traumatic stress disorder (PTSD), and drug addiction. The gene discussed is OPRK1; the disease is major depressive disorder.